Exelixis (EXEL) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • Thursday
Exelixis Announces Third Quarter 2026 Financial Results and Provides Corporate UpdateBusiness Wire • Thursday
Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockMarketBeat • Monday
Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/22/26
Exelixis to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026Business Wire • 10/15/26
Exelixis Eyes Oncology Deals, Readies Zanzalintinib Launch as Cabozantinib Tops $3BMarketBeat • 09/17/26
Exelixis, Inc. (EXEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26